The Breakdown
MoleMap · Map Your Future
MoleMap stopped selling fear and started selling the future
Skin-check reminders usually lean on risk and worry. MoleMap's own CMO (chief marketing officer) says reframing the message around travel, fitness and family moments drove its best quarter on record, though every number in that claim comes from the company itself.
The TL;DR (too long; didn't read)
- MoleMap ANZ's 'Map Your Future' campaign reframes skin checks around people's future plans, like travel, fitness and family milestones, rather than fear-based risk messaging, running July to September 2026 across TV, radio, billboards, bus stops, retail screens and social, with a second phase from 1 November.
- MoleMap's own CMO, writing an op-ed for B&T, reports the campaign was seen or heard 34 million times and that MoleMap had its best July-to-September quarter on record (25,639+ bookings, up 20% year on year), modelling about 2,000 of those bookings, roughly 2.8 times media spend, as directly attributable to the campaign.
- Every figure, including the booking attribution model, is self-reported by the brand's own CMO in an opinion piece, not independently measured or audited.
01
Selling the future, not the check
Swapping fear-based messaging ('you might have skin cancer') for aspiration-based messaging ('don't let a skin check get in the way of your trip') changes what the ad is actually asking someone to feel before it asks them to act.
It's a bet that people respond better to protecting something they're looking forward to than to being reminded of a risk they'd rather not think about.
Read the original reporting
- How A Social Idea Became MoleMap’s Brand Platform ↗
B&T · 28 Oct 2026